Among the 10 GBP1-related proteins, IFIT3 is an interferon-induced protein, and high IFIT3 expression in hepatocellular carcinoma patients predicted a better response to IFN-α therapy (Yang et al., 2017). Here, GBP1 is linked to hepatocellular carcinoma.